# American Association for Laboratory Animal Science Aalas

Grantmaking public charity, Memphis, Tennessee. EIN 36-2445901.

Source: the foundation’s own IRS returns, read November 20, 2026, as shown by the Alleviate Index. https://sites.alleviate.org/index/funder/american-association-for-laboratory-animal-science-aalas-362445901

## Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether American Association for Laboratory Animal Science Aalas accepts applications.

## What it gave

- Grants paid: $132,445 (Year ending December 2024)
- Grants listed: 6 (To organizations, on that return)
- Typical grant: $14,575 (Half fall between $7,083 and $31,362)

- December 2024: Grants paid $132,445; Grants listed 6
- December 2023: Grants paid $109,857; Grants listed 4

From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.

## What it funds, and where

- Focus, by share of linked grant dollars: None of its grants could be linked to a charity with certainty, so no focus is shown.
- Where it gave, by number of grants: Massachusetts 2, California 1, South Carolina 1, Minnesota 1, Washington 1, Ohio 1, Michigan 1, New York 1

## Recent grants to organizations

- MEDICAL UNIVERSITY OF SOUTH CAROLINA (Charleston, South Carolina): $50,000, year ending December 2024. PHARMACOKINETICS AND EFFICACY OF LONG-ACTING TRANSDERMAL FORMULATION OF BUPRENORPHINE (ZORBIUM) IN NOD-SCID-GAMMA AND C57BL/6 MICE
- BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California): $34,600, year ending December 2024. THE EFFECTS OF TRANSPORT STRESS ON BEHAVIORAL AND PHYSIOLOGICAL INDICATORS OF WELFARE IN MICE
- MASSACHUSETTS INSTITUTE OF TECHNOLOGY (Cambridge, Massachusetts): $21,650, year ending December 2024. PHARMACOKINETICS AND SAFETY OF PHARMACEUTICAL-GRADE, EXTENDED-RELEASE MELOXICAM IN ZEBRA FINCHES (TAENIOPYGIA GUTTATA) AND INTERSPECIES COMPARISON OF DRUG METABOLISM
- UNIVERSITY OF MINNESOTA (St Paul, Minnesota): $7,500, year ending December 2024. DOSE-DEPENDENT EFFECTS OF BUPRENORPHINE ON IMMUNE MODULATION IN NONHUMAN PRIMATES
- SEATTLE CHILDREN'S RESEARCH INSTITUTE (Seattle, Washington): $6,944, year ending December 2024. EVALUATING THE IMPACT OF EXPERIENCE LEVEL ON CLINICAL AND HISTOLOGIC OUTCOMES FOLLOWING RETRO-ORBITAL INJECTION IN MICE.
- MCMASTER UNIVERSITY (Hamilton, CA): $6,649, year ending December 2024. IMPACT OF MAROPITANT CITRATE ON ACUTE RADIATION SICKNESS IN NSG MICE UNDERGOING TOTAL BODY IRRADIATION
- CENTRAL MICHIGAN UNIVERSITY (Mount Pleasant, Michigan): $47,974, year ending December 2023. IMPACT OF ENVIRONMENTAL ENRICHMENT ON AGGRESSION AND WELFARE IN CICHLID FISH
- CORNELL UNIVERSITY (Ithaca, New York): $46,961, year ending December 2023. MORPHINE PHARMACOKINETICS AND PHARMACODYNAMICS IN PIGS
- HARVARD MEDICAL SCHOOL (Boston, Massachusetts): $7,500, year ending December 2023. EVALUATION OF THE ANTIMICROBIAL EFFECTS OF BLUE LIGHT AND HYPOCHLOROUS ACID ON THE MACAQUE CRANIAL IMPLANT-TISSUE MARGIN MICROBIOTA
- THE OHIO STATE UNIVERSITY (Columbus, Ohio): $6,532, year ending December 2023. EFFICACY OF LONG-ACTING TRANSDERMAL BUPRENORPHINE IN C57BL/6 MICE

Method and sources: https://sites.alleviate.org/index/method#funders
